30 Oct 2017 15:19
MedaPhor Group plc
("MedaPhor" or the "Company")
Director Appointment
MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces the appointment of Andrew Charles Barker as a Non-Executive Director effective immediately. Upon joining, Andrew will succeed David Baynes as Chairman of the Remuneration Committee, while David will retain the Chairmanship of the Company's Audit Committee.
Andrew, 59, has over 30 years' experience in senior management of technology and software businesses and in venture capital, having been involved in the early stages of internet computing with Sun Microsystems in Silicon Valley, later going on to help build Intel's venture arm in the UK.
He is an experienced NED and investor in early stage companies with disruptive technology. His portfolio has a med-tech focus and, in addition to his position as a Director of Intelligent Ultrasound Limited (acquired by MedaPhor on 6 October 2017, RNS number: 8775S), Andrew is the Chairman of Brainomix, a University of Oxford medical imaging spin out and a Partner of Anchard Associates LLP.
Riccardo Pigliucci, Chairman of MedaPhor, said: "I am very pleased to welcome Andrew to the Board. In addition to bringing a wealth of relevant experience, his appointment highlights the importance of Intelligent Ultrasound to the enlarged group and will facilitate its integration into MedaPhor."
Other than that set out above, there are no other matters that are required to be disclosed under Schedule 2 paragraph (g) of the AIM Rules in relation to the appointment of Mr. Barker.
Enquiries:
MedaPhor Group plc | www.medaphor.com | |
Stuart Gall, CEO | Tel: +44 (0) 29 2075 6534 | |
|
| |
Cenkos Securities | Tel: +44 (0) 20 7397 8900 | |
Bobbie Hilliam (Nominated Advisor) |
| |
Michael Johnson / Julian Morse (Corporate Broking) |
| |
| ||
Walbrook PR | Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com | |
Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001 | |
About MedaPhor (www.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops advanced hi-fidelity haptic and manikin based training simulators, clinical image analysis software tools, augmented reality based needle guidance software and artificial intelligence based automated scanning software for all medical practitioners.
Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:
Ultrasound Simulation and Training
Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Point-of-Care simulator platform (launching January 2018). Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.
Intelligent Ultrasound
Focuses on developing augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. ScanNav uses machine-learning based algorithms to automatically access and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.